Dr. Bent Jakobsen co-founded Avidex, the predecessor company to Adaptimmune, in March 1999. As our scientific founder, he provides strategic and advisory research input. Dr. Jakobsen co-founded Avidex whilst he was at the Institute of Molecular Medicine at the University of Oxford, where he was Head of the Immune Receptor Group from 1993 to July 2000. This group is recognised as one of the leading international laboratories in molecular immunology and is a world leader in recombinant immune receptor technology. Prior to this, he was a Senior Research Fellow of the Danish Natural Research Council, Aarhus, Denmark. This followed three years as a Post-doctoral researcher at the Laboratory of Molecular Biology of the Medical Research Council in Cambridge. Dr. Jakobsen was formerly CSO of Adaptimmune since its inception as a spin-out of MediGene in 2008.

 Dr. Bent Jakobsen co-founded Avidex, the predecessor company to Adaptimmune, in March 1999. As our scientific founder, he provides strategic and advisory research input. Dr. Jakobsen co-founded Avidex whilst he was at the Institute of Molecular Medicine at the University of Oxford, where he was Head of the Immune Receptor Group from 1993 to July 2000. This group is recognised as one of the leading international laboratories in molecular immunology and is a world leader in recombinant immune receptor technology. Prior to this, he was a Senior Research Fellow of the Danish Natural Research Council, Aarhus, Denmark. This followed three years as a Post-doctoral researcher at the Laboratory of Molecular Biology of the Medical Research Council in Cambridge. Dr. Jakobsen was formerly CSO of Adaptimmune since its inception as a spin-out of MediGene in 2008.